BBIOBridgeBio Pharma

Median target
$110
calls from the last 12 months
Implied return
+63.4%
median target vs. price
Coverage
24 analysts · 27 calls
updated in the last 12 months
Consensus
21/3/0+21 net
Buy / Hold / Sell

Which analysts are behind BBIO's consensus?

See every current rating, price target and the analysts' track records for BridgeBio Pharma — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 24 analysts with calls on BBIO updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

BBIO elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-08-19InsidersKumar NeilChief Executive OfficerInsider sale8.1K sh @ $83.86 · planned trade$679K
2026-08-19InsidersKumar NeilChief Executive OfficerInsider sale1.8K sh @ $84.69 · planned trade$152K
2026-08-19InsidersKumar NeilChief Executive OfficerInsider sale100 sh @ $85.65 · planned trade$9K
2026-08-18InsidersKumar NeilChief Executive OfficerInsider sale17.3K sh @ $82.21 · planned trade$1.4M
2026-08-18InsidersKumar NeilChief Executive OfficerInsider sale14.6K sh @ $82.99 · planned trade$1.2M
2026-08-18InsidersKumar NeilChief Executive OfficerInsider sale1.9K sh @ $81.15 · planned trade$154K
2026-08-18InsidersKumar NeilChief Executive OfficerInsider sale1.2K sh @ $83.77 · planned trade$100K
2026-07-30InsidersApuli MaricelChief Accounting OfficerInsider sale2.0K sh @ $80.06 · planned trade$160K
2026-05-11CongressGilbert CisnerosCA-CA39Purchasesince trade +3.0%, vs market -0.3%$1K–$15K
2025-09-22CongressGilbert CisnerosCA-CA39Purchasesince trade +29.2%, vs market +14.4%$1K–$15K

More: congressional trades on BBIO · insider activity · executive branch · trending